PF 6274484 is primarily utilized in the field of pharmaceutical research, where it plays a significant role in the development of new therapeutic agents. Its application is particularly focused on targeting specific biochemical pathways involved in disease processes, making it a valuable compound for drug discovery and preclinical studies. In oncology research, PF 6274484 is investigated for its potential to inhibit certain enzymes or proteins that are crucial for cancer cell proliferation and survival. This makes it a promising candidate for the development of targeted cancer therapies, aiming to reduce the growth of tumors while minimizing damage to healthy cells. Additionally, PF 6274484 is explored in the context of inflammatory and autoimmune diseases. Researchers are studying its ability to modulate immune responses, which could lead to the creation of novel treatments for conditions characterized by excessive or inappropriate immune activity. The compound is also of interest in neuroscience, where it is being examined for its effects on neurological disorders. By influencing specific neural pathways, PF 6274484 may contribute to the development of drugs that can alleviate symptoms or modify the course of diseases such as Alzheimer's, Parkinson's, or depression. Overall, PF 6274484 is a versatile chemical entity with broad potential applications in the development of new and effective treatments across various medical fields. Its role in advancing our understanding of disease mechanisms and contributing to the creation of innovative therapies underscores its importance in contemporary pharmaceutical research.